Hemostatic changes in patients with end stage renal disease undergoing hemodialysis

被引：38
作者：
Alves Rios, Danyelle Romana [1 ]
Carvalho, Maria das Gracas [1 ]
Lwaleed, Bashir A. [1 ]
Simoes e Silva, Ana Cristina [1 ]
Gomes Borges, Karina Braga [1 ]
SantAna Dusse, Luci Maria [1 ]
机构：
[1] Univ Fed Minas Gerais, Fac Farm, Clin & Toxicol Anal Dept, BR-31270901 Belo Horizonte, MG, Brazil
来源：
CLINICA CHIMICA ACTA | 2010年 / 411卷 / 3-4期
关键词：
Hemodialysis; Coagulation; Fibrinolysis; Platelets; End stage renal disease; VASCULAR ACCESS THROMBOSIS; FACTOR PATHWAY INHIBITOR; ENDOTHELIAL-CELL MARKERS; GLYCOPROTEIN-IIB-IIIA; UREMIC PATIENTS; ARTERIOVENOUS-FISTULA; PLATELET-AGGREGATION; TISSUE FACTOR; MAINTENANCE HEMODIALYSIS; GUANIDINOSUCCINIC ACID;
D O I：
10.1016/j.cca.2009.11.022
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Patients undergoing hemodialysis may show both thrombotic complications and bleeding abnormalities. Hemostatic changes in patients on hemodialysis may result from alterations in vessel wall integrity and platelet function, and reduced blood flow in the native arteriovenous fistula. Vascular complications represent 20-25% of all hospitalizations of patients on hemodialysis. Literature survey revealed that changes in the hemostatic system may play a major role in vascular complications observed in these patients. Thus, it is essential to investigate hemostatic alterations in patients on hemodialysis so that adequate regimes for anticoagulant therapy could be implemented. In this review we discuss hemostatic abnormalities in end stage renal disease patients undergoing hemodialysis. (c) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码：135 / 139
页数：5
相关论文
共 78 条
  • [11] INITIATION OF BLOOD-COAGULATION AT ARTIFICIAL SURFACES
    COLMAN, RW
    SCOTT, CF
    SCHMAIER, AH
    WACHTFOGEL, YT
    PIXLEY, RA
    EDMUNDS, LH
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 516 : 253 - 267
  • [12] Cross-talk between inflammation, coagulation/fibrinolysis and vascular access in hemodialysis patients
    Costa, E.
    Rocha, S.
    Rocha-Pereira, P.
    Castro, E.
    Reis, F.
    Teixeira, F.
    Miranda, V.
    Faria, M. Do Sameiro
    Loureiro, A.
    Quintanilha, A.
    Belo, L.
    Santos-Silva, A.
    [J]. JOURNAL OF VASCULAR ACCESS, 2008, 9 (04) : 248 - 253
  • [13] EFFECTS OF EXOGENOUS UREA, CREATININE, AND GUANIDINOSUCCINIC ACID ON HUMAN PLATELET AGGREGATION IN-VITRO
    DAVIS, JW
    PHILLIPS, PE
    GRAHAM, BA
    MCFIELD, JR
    [J]. BLOOD-THE JOURNAL OF HEMATOLOGY, 1972, 39 (03): : 388 - &
  • [14] DeMarchi S, 1996, J AM SOC NEPHROL, V7, P1169
  • [15] PLATELET FUNCTION IN RENAL FAILURE
    EKNOYAN, G
    WACKSMAN, SJ
    GLUECK, HI
    WILL, JJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (13) : 677 - &
  • [16] Erdem Y, 1996, NEPHROL DIAL TRANSPL, V11, P1299
  • [17] Fischer Karl-Georg, 2007, Hemodial Int, V11, P178, DOI 10.1111/j.1542-4758.2007.00166.x
  • [18] Resistance to activated protein C (APC): Mutation at ARG(506) of coagulation factor V and vascular access thrombosis in haemodialysis patients
    Fodinger, M
    Mannhalter, C
    Pabinger, I
    Koizar, D
    Rintelen, C
    Horl, WH
    SunderPlassmann, G
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (04) : 668 - 672
  • [19] The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients
    Fukasawa, M
    Matsushita, K
    Kamiyama, M
    Mikami, Y
    Araki, I
    Yamagata, Z
    Takeda, M
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (03) : 637 - 642
  • [20] PREALBUMIN AND LIPOPROTEIN(A) IN HEMODIALYSIS - RELATIONSHIPS WITH PATIENT AND VASCULAR ACCESS SURVIVAL
    GOLDWASSER, P
    MICHEL, MA
    COLLIER, J
    MITTMAN, N
    FEIN, PA
    GUSIK, SA
    AVRAM, MM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (01) : 215 - 225
12345678